on Wellgistics Health, Inc. (NASDAQ:WGRX)
Wellgistics Health Expands Platform with New Partnerships and Products
Wellgistics Health, Inc. (NASDAQ:WGRX) has reported a strong Q2 2025. The company added 116 new pharmaceutical manufacturer partnerships, introduced over 12,400 new products, and welcomed 275+ pharmacies to its platform. This growth reflects their commitment to creating a modern drug ecosystem aimed at connecting manufacturers directly to pharmacies, providers, employers, and patients.
The company's CEO, Brian Norton, highlighted the ongoing structural transformation. Wellgistics is focused on delivering speed and visibility to its partners. The expanded network aims to facilitate real-time, patient-focused drug access on a national scale.
The Wellgistics platform manages the entire prescription journey, with a focus on advancing direct-to-patient care programs. This includes wholesale distribution, digital Rx routing, and various hub services designed to streamline prescription fulfillment.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Wellgistics Health, Inc. news